Phenotyping System Articles & Analysis
12 news found
Hit identification and optimization Creative Diagnostics provides comprehensive support for drug screening using virtual, biochemical, biophysical, cellular and phenotyping platforms. The company offers phenotyping, biochemical and cellular assays for microbial and cellular growth inhibition in recombinant human cells or primary cells, bacteria, viruses, yeast ...
The company is working on an AI-driven Retinal Deep Phenotyping™ solution to detect chronic disease biomarkers, which can enhance the diagnosis of neurodegenerative conditions such as Alzheimer’s. ...
The Selux platform will become the system of choice for healthcare providers dedicated to providing best-in-class septic and other infectious diseases patient care." ...
Wilson will lead the company's revenue growth for its rapid antimicrobial susceptibility testing (AST) technology as Selux prepares to commercialize its Next Generation 'Phenotyping' (NGP) platform. "Having an executive of John's caliber and experience join Selux greatly enhances our leadership team. ...
2021 Optina, an innovative diagnostics company leading the field of Retinal Imaging, Brain Health and Systemic Diseases Diagnostics, announced today the closing of an CA$24.8 million Series A round of funding. ...
National Institutes of Health (NIH) to help the company commercialize its Next Generation 'Phenotyping' (NGP) platform for rapid antimicrobial susceptibility testing (AST). ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. ...
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. ...
Optina Diagnostics announces today that it has signed an agreement with the Alzheimer Center Amsterdam, part of the Amsterdam University Medical Center to pursue the study of Optina’s Retinal Deep Phenotyping Platform™? in a cohort of 100 subjects. July 29, 2020 Optina Diagnostics announces today that it has signed an agreement with the Alzheimer Center Amsterdam, part of the ...
Alzheimer’s awareness month, Optina Diagnostics and Wagner Macula Retina Center will Collaborate to Conduct a Clinical Study and Develop a Unique in-community Patient access Program Aimed to Identify the Causes of Memory Loss through Eye Diagnostics, November 6th 2019 Optina Diagnostics Optina Diagnostics, a world leading company in retinal imaging and artificial intelligence with a vision ...
Do you have senior moments? Are you concerned your memory loss may be a sign of something beyond normal aging? An innovative eye exam is helping physicians answer these questions with confidence. Optina Diagnostics, a world leader in retinal imaging technology and AI with a vision to change mindsets when it comes to brain health and Dr. Jean-Claude Tardif’s research group from the Montreal ...
Poster sessions: Rapid Antimicrobial Susceptibility Testing with Broad Antibiotic Menus Using 384-Well: Saturday, Jun. 22, 2019; Presentation Time 1: 11 am-12 pm, Presentation Time 2: 4 pm - 5 pm; CPHM-834; Presenter, Selux Diagnostics, Eric Stern, PhD This poster session describes Selux Diagnostics' next-generation phenotyping (NGP) platform, which employs automated, rapid ...